“Evaluation of Microbial Risk Factors in Relation to Clinical Effectiveness of Off-Label Bevacizumab Use for Retinal Disease Treatment: Research Article” (2026) Pak-Euro Journal of Medical and Life Sciences, 9(1), pp. 25–34. doi:10.31580/pjmls.v9i1.3417.